Objective: Infants undergoing cardiac surgery often have postoperative bleeding contributing to the occurrence of adverse events. A quantitative evaluation of postoperative bleeding has not been well described.
Infants who undergo cardiac surgery within the first year of life often experience significant postoperative bleeding after admission to the intensive care unit (ICU). 1 In addition to the extensive suture lines, increased hemodilution, activation of the coagulation system, and hemostatic derangements after cardiopulmonary bypass (CPB) increase the risk of postoperative bleeding. [1] [2] [3] [4] Inherent deficiencies in antithrombin and other coagulation proteins can also prevent adequate hemostasis during and after CPB. 5, 6 Excessive postoperative bleeding will often be treated with blood products, including packed red blood cells (PRBCs), fresh frozen plasma, platelets, and thawed cryoprecipitate. In cases of severe bleeding, activated factor VII will often be administered to achieve adequate hemostasis. 7 Laboratory tests, including the thromboelastogram, have allowed for specific targeting of deficient areas of the coagulation system during ongoing bleeding. 8 When factor and product replacement have failed to achieve hemostasis, surgical exploration will usually be undertaken.
Excessive postoperative bleeding requires replacement with blood transfusions. Although safe during administration, blood transfusions carry several risks that can affect morbidity and mortality after cardiac surgery. Adult data have demonstrated increased mortality risk in association with PRBC transfusion after coronary artery bypass grafting 9 and a significant effect on long-and short-term survival after all types of adult heart surgery. 10 Pediatric data have demonstrated an increased duration of mechanical ventilation and ICU length of stay in relation to blood transfusions, with no demonstrable survival benefit for aggressive transfusion strategies compared with conservative transfusion strategies. [11] [12] [13] [14] [15] [16] [17] The primary goal of the present study was to examine the relationship of early postoperative bleeding in infants with surgical mortality and adverse events. We hypothesized that increasing amounts of postoperative bleeding would be associated with an increased mortality risk and adverse events, including a prolonged duration of mechanical ventilation and ICU length of stay. In particular, we focused on a quantitative evaluation of early postoperative bleeding after infant cardiac surgery and its effect on mortality.
METHODS

Study Design
The Children's Healthcare of Atlanta institutional review board approved the present study. Data were collected from the individual medical records and our institutional surgical database. All infants <1 year of age who had undergone cardiac surgery with CPB from August 1, 2008 through December 31, 2011 were included in the present analysis. Early postoperative bleeding was defined as bleeding that occurred within the first 12 hours after ICU admission. All patients included in the analysis were treated in the cardiac ICU postoperatively.
In addition to the volume of postoperative bleeding, the data collected included age, weight, height, cardiac anatomy, presence of chromosomal anomaly, Risk Adjustment for Congenital Heart Surgery (RACHS) score, perfusion time in the operating room, blood products received in the operating room, blood products received in the ICU, mechanical ventilation duration, length of ICU stay, in-hospital mortality, postoperative cardiac arrest, postoperative infection confirmed by positive wound culture or blood culture findings, delayed sternal closure, need for surgical re-exploration, need for mechanical circulatory support, and need for continuous renal replacement therapy.
Each operative admission was treated separately. In patients who underwent >1 operation during an admission, the primary operation for which they had been admitted to the hospital was chosen for analysis. As such, the patients who underwent a stage I Norwood operation as a newborn and a subsequent cavopulmonary anastomosis at 4 months of age were included in the analysis as 2 unique encounters.
The CPB anticoagulation protocol at the Children's Healthcare of Atlanta during the entire study period consisted of a single bolus dose of 500 U/kg of unfractionated heparin immediately before the initiation of CPB. Monitoring was achieved with activated clotting times, with a goal of>500 seconds. Repeat doses of heparin (100 U/kg) were given to maintain the activated clotting time >500 seconds throughout the duration of CPB. Aminocaproic acid (Amicar; Clover Pharmaceuticals, Marietta, Ga) was routinely administered to infants undergoing repeat sternotomy. After CPB, a dose of protamine (5 mg/kg) was administered to reverse anticoagulation. Ongoing bleeding in the operating room was treated with platelets, thawed cryoprecipitate, and fresh frozen plasma. In cases of severe bleeding for which a surgical cause could not be identified, activated factor VII was used.
The vast majority of patients underwent bicaval cannulation and moderate hypothermia (28 -32 C), except for neonates undergoing aortic arch reconstruction or a first stage Norwood procedure, for whom hypothermia to 18 C was typically used with regional cerebral perfusion. The use of profound hypothermic circulatory arrest for >2 or 3 minutes was rare. The hematocrit was maintained at >28%, often with the use of hemofiltration during CPB. Modified venovenous ultrafiltration at the termination of CPB, particularly in neonates was commonly (but not universally) used, according to surgeon preference. The cell saver was also available for virtually all patients and was generally preferred over PRBCs both in the operating room and in the ICU.
Patients who continued to have significant bleeding on admission to the cardiac ICU were treated further with multiple blood products, including fresh frozen plasma, platelets, thawed cryoprecipitate, and PRBCs. In severe cases, repeat dosing of activated factor VII was used. The coagulation tests used included the prothrombin time, activated partial thromboplastin time, international normalized ratio, and anti-Xa assay. Thromboelastography and platelet mapping were also used more recently to help target specific areas of the coagulation system, if the bleeding was difficult to control. When the bleeding could not be controlled medically, or if signs or symptoms of pericardial tamponade developed, surgical exploration was undertaken to identify a specific source of bleeding.
The primary outcome of the present study was in-hospital mortality. Secondary outcomes were the mechanical ventilation duration and length of ICU stay.
Statistical Analysis
Statistical analysis was performed using STATA, version 12.0, software (StataCorp LP, College Station, Tex) and Statistical Analysis Software, version 9.3 (SAS Institute Inc, Cary, NC). Univariate analysis was performed using Student's t test or analysis of variance for continuous data and Fisher's exact test or c 2 for categorical data. Multivariate logistic and linear regression analysis was undertaken to adjust for covariates. To predict the effect of postoperative bleeding on mortality risk, all variables with P<.1 on univariate analysis were entered into a multivariate logistic regression analysis.
RESULTS
A total of 1071 infants<1 year of age underwent cardiac surgery with CPB during the study period. To quantify the bleeding amounts, the patients were stratified by quartile according to the quantity of bleeding during the first 12 postoperative hours: 0 to 1.19, 1.20 to 2.00, 2.01 to 4.19, and 4.20 mL/kg/h. The patient characteristics are summarized in Table 1 .
The patients in the higher quartiles were younger, weighed less, and had greater RACHS scores and longer perfusion times (P <.001). Patients in the highest quartile had a median age of 8 days (range, 0-346) compared with a median age of 103 to 158 days in the 3 lower quartiles (P <.001). The median weight in the highest quartile was 3.4 kg (range, 2.0-8.7) compared with a median weight of 4.4 to 5.8 kg in the 3 lower quartiles (P<.001). The median RACHS score in the 2 highest quartiles was 3 compared with a score of 2 in the 2 lower quartiles (P <.001). The perfusion time also increased with increasing quartile. The median perfusion time in the lowest quartile was 76 minutes (range, 18-211), increasing to 139 minutes in the highest quartile (range, 31-361; P <.001).
Single ventricle anatomy was present in 22% to 30% of the patients across the quartiles, with a trend toward statistical significance (P ¼ .08). Chromosomal anomalies were present in 11% to 17%, and heterotaxy syndrome ranged Abbreviations and Acronyms CPB ¼ cardiopulmonary bypass ICU ¼ intensive care unit PRBC ¼ packed red blood cell RACHS ¼ Risk Adjustment for Congenital Heart Surgery from 1.9% to 5%, with no significant difference across the quartiles. The surgical details and outcomes are summarized in Table 2 . Mortality increased across the quartiles, with 10% mortality in the highest bleeding quartile, 4.5% in the third, 1.1% in the second, and 0.4% in the lowest quartile (P <.001). The overall hospital mortality for all patients analyzed was 4.1%. The interval from surgery to death was similar in the second and fourth quartiles (median, 16 and 14 days, respectively) and longest in the third quartile (median, 21 days). One death occurred in the lowest quartile 1 day after surgery ( Figure 1 ).
The PRBC volume transfused increased across the quartiles, with patients in the highest quartile receiving a median of 8.8 mL/kg (range, 0-395) of transfused blood during the first 12 postoperative hours. The median PRBC volume transfused was 0 for the 3 lower quartiles, although the mean volume increased from 3.0 mL/kg within 12 hours in the lowest quartile to 6.7 mL/kg within 12 hours in the third quartile. Of the 1071 patients in our cohort, 644 did not receive any PRBC transfusions after surgery. The cell saver that was administered was not considered transfused PRBCs. The mean volume transfused in the highest quartile was 22 mL/kg within 12 hours.
The duration of mechanical ventilation increased across the quartiles, with the lowest 3 quartiles having a median duration of 22 to 42 hours and the highest quartile, a median duration of 119 hours (range, 0-3632; P <.001). The ICU length of stay was similar, with a median range of 51 to 93 hours in the 3 lowest quartiles and 180 hours (range, 22-2931) in the highest quartile (P <.001; Figure E1 ).
Other factors that increased across quartiles included mechanical circulatory support, postoperative cardiac arrest, delayed sternal closure, postoperative renal replacement therapy (continuous venovenous hemofiltration), and reoperation to control bleeding. The infection rates did not differ significantly across the quartiles.
Using multivariate logistic regression analysis, after adjustment for age, weight, single ventricle anatomy, RACHS score, and perfusion time, an increasing bleeding quartile was independently associated with mortality risk, with an odds ratio of 1.15 (95% confidence interval 1.07-1.22; P <.001). Although PRBC transfusion emerged as a significant risk factor for mortality on univariate analysis Tables 3 and 4 . The effect of postoperative bleeding and PRBC transfusion on the duration of mechanical ventilation and ICU length of stay was also assessed using multivariate linear regression analysis. Controlling for age, RACHS score, perfusion time, and single ventricle anatomy, the effect of bleeding volume and PRBC transfusion was assessed. Patients with a greater bleeding volume had a longer duration of mechanical ventilation (P<.001) and ICU length of stay (P ¼ .005). Patients who received PRBC transfusions also had a longer mechanical ventilation duration (P ¼ .01) and ICU length of stay (P ¼ .003).
DISCUSSION
This is the first study to our knowledge to quantitatively evaluate the effect of postoperative bleeding on hospital mortality risk after infant cardiac surgery. Although previous studies have examined the risk factors for increased postoperative blood loss, 1, 4 the effect on increased mortality risk was not described. In addition, the adverse effects of blood transfusions, including a longer duration of mechanical ventilation and ICU stay, have been well described in the pediatric data 11, 12, 18 ; however, the effect on mortality risk has not been.
We identified several risk factors for increased blood loss in the postoperative period. In agreement with the findings of Williams and colleagues, 1,4 younger age and lower weight both increased the risk and quantity of postoperative bleeding. A greater RACHS score and longer perfusion time were also associated with increased mortality risk and quantity of bleeding. The bleeding risk was not affected by the presence of a chromosomal anomaly, or heterotaxy syndrome, although single ventricle anatomy was associated with increased mortality risk on univariate analysis.
The mortality risk was significantly affected by an increased quantity of bleeding, with the risk of death more than doubling with each increased quartile. Aside from 1 patient in the lowest quartile who died on postoperative day 1, the median interval from surgery to death ranged from 16 to 24 days in the 3 highest quartiles. Several factors could have influenced these intervals. Blood transfusions are known to cause inflammation, especially in the pulmonary system, when given in large quantities, known as transfusion-associated lung injury. 19, 20 Infants who experience significant postoperative hemorrhage tended to receive larger quantities of transfused blood products, increasing their risk of transfusion-associated lung injury. With increased lung inflammation, the duration of mechanical ventilation and its associated complications, including increased mortality, increased. Other factors that influenced the increased mortality risk were the greater incidence of postoperative cardiac arrest, mechanical circulatory support, and renal replacement therapy, all of which are independent risk factors for mortality after infant cardiac surgery.
The duration of mechanical ventilation and ICU length of stay were both independently affected by an increasing volume of postoperative bleeding. This remained statistically significant when controlling for other significant confounding variables. We attributed this to several factors. In addition to those mentioned, the patients with ongoing bleeding were more likely to return from the operating room with an open sternum and require subsequent surgical exploration because of bleeding, both of which increased the duration of mechanical ventilation and ICU length of stay. However, the infection rates did not differ across the quartiles. This was in contrast to the findings of several previous studies that identified delayed sternal closure, length of ICU stay, and duration of mechanical ventilation as risk factors for postoperative infection. [21] [22] [23] All patients at our institution were treated with perioperative cefazolin for the first 48 hours after surgery, and those with an open sternum were treated with vancomycin and gentamycin until 24 hours after delayed sternal closure. These preemptive antibiotics might have lowered the infection risk across all groups. In addition, the objective of the present study was to analyze the association of postoperative bleeding with the clinical outcomes. The study was not designed to assess the effect of red blood cell transfusion per se on outcomes.
Blood transfusions are frequently given after infant cardiac surgery, and their adverse effect on outcomes has continued to emerge. Although the primary goal of the present study was to identify the increased mortality risk associated with increasing quantities of postoperative bleeding, PRBC transfusions were found to increase mortality risk. Although this effect did not remain on multivariate analysis, we raise the concern that the need for increased transfusions in the setting of significant bleeding plays a role in increasing mortality risk. Given the retrospective nature of the present study, it was difficult to differentiate the exact contributions that early postoperative bleeding and the resultant blood transfusions had on increased mortality risk.
We found an independent relationship between PRBC transfusion and an increased mechanical ventilation duration and ICU length of stay. These findings were in line with the findings of Salvin and colleagues 11 and Kipps and colleagues. 12 From our results, we stress the importance achieving adequate hemostasis in the operating room before ICU admission. All the risk factors identified in the present study occurred postoperatively in the ICU. By meticulously controlling postoperative bleeding in the operating room, a significant effect could be made on patient mortality. Although it is self-evident that 1 of the goals of congenital heart surgery is to minimize bleeding, strategies to achieve hemostasis must be balanced against the potential risks. Aggressive strategies to establish hemostasis could induce a prothrombotic state, leading thrombotic vessel occlusion. Some centers have advocated the use of fresh whole blood to minimize inflammation and induce a more favorable anticoagulation profile. Others have suggested that the use of aprotinin (currently not available in the United States) might lessen postoperative bleeding. 14, [24] [25] [26] In addition, given the independent association of blood transfusions and mortality, we stress the importance of weighing the risks and benefits of each transfused blood product, especially PRBCs, before administration. Their potential benefits, including increased oxygen carrying capacity and improved hemodynamics, have been well described 16, 18 ; however, the adverse effects are an important consideration, even for patients with ongoing bleeding. [27] [28] [29] [30] The present study had several important limitations. This was a single-center, retrospective analysis, and practices regarding hemostasis and the treatment of ongoing bleeding differ across institutions. In addition, several confounders were present that influenced the primary and secondary outcomes of the present study. Although these were controlled for in our multivariate analysis, their independent effect cannot be ignored. Although the independent association of an increasing quantity of postoperative bleeding and mortality was convincing, the association of transfusion was less so. A randomized controlled trial to analyze the independent effect of blood transfusions after infant cardiac surgery is necessary to provide definitive guidelines for their use.
CONCLUSIONS
Early postoperative hemorrhage after infant cardiac surgery was independently associated with increased inhospital mortality risk, a longer duration of mechanical ventilation, and an increased ICU length of stay. The longer interval from surgery to death seems to indicate that several mechanisms, other than bleeding itself and that might include factors such as inflammation and transfusion volume, could contribute to mortality. PRBC transfusions were also independently associated with an increased duration of mechanical ventilation and ICU length of stay. Initiatives to limit postoperative bleeding and critically appraise PRBC transfusion practices are warranted.
